Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Nanning Xinzizhu to Distribute AOTI Wound Healing Device in China

publication date: Jan 18, 2019

Nanning Xinzizhu Trading acquired China distribution rights to a medical device aimed at treating chronic wounds made by AOTI of Oceanside, CA. AOTI developed the Topical Wound Oxygen (TWO2) device that delivers oxygen to chronic wounds, especially diabetic ulcers. Initially, both AOTI and Xinzizhu will work together to obtain NMPA registration of the TWO2 product line, while they increase awareness of the new device. The two companies signed a multi-year agreement that includes minimum sales totaling close to $18 million. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital